NOVEL SARS-COV-2 PANDEMIC TRANSMISSION WITH ONGOING ANTIVIRAL THERAPIES AND VACCINE DESIGN

被引：0

作者：

Yameen, Muhammad ^{[1
]}

Sattar, Sara ^{[3
]}

Khalid, Ayesha ^{[3
]}

Aslam, Muhammad Aamir ^{[2
]}

Zafar, Nishat ^{[2
]}

Saeed, Muhammad Hassan ^{[4
]}

Arif, Muhammad Haseeb ^{[4
]}

Jahangeer, Muhammad ^{[1
]}

Qadeer, Azka ^{[2
]}

Hussain, Shoukat ^{[1
]}

Aamir, Muhammad ^{[2
]}

Mukhtar, Sania ^{[2
]}

Nasir, Huma ^{[2
]}

Shahzad, Asif ^{[1
]}

机构：

[1] Govt Coll Univ, Dept Biochem, Faisalabad 38000, Pakistan

[2] Univ Agr Faisalabad, Inst Microbiol, Faisalabad 38000, Pakistan

[3] COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan

[4] Univ Punjab, Dept Microbiol & Mol Genet, Lahore, Pakistan

来源：

ADVANCEMENTS OF MICROBIOLOGY | 2021年 / 60卷 / 01期

关键词：

SARs-CoV-2; WHO; viral genome; COVID-19; SARS-COV; CORONAVIRUS; COVID-19; MERS;

D O I：

10.21307/PM-2021.60.1.02

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Starting from the end of 2019 the new SARs-CoV-2 virus, in the period of a few months, had spread to 210 countries and its territories. The Wuhan wild animal market, in Hubei province, China is considered the epicenter of this pandemic. WHO declared the name COVID-19 to designate the disease caused by the SARS-CoV-2 virus. It is the third coronavirus pandemic after SARS in 2002-2003 and MERS-CoV in 2012. Genome sequencing of this new COVID-19/SARS-CoV-2 virus shows slight genetic diversity when compared to other coronaviruses. Owing to its pathogenesis, and less known replication cycle, no universal antiviral treatment can be applied and vaccine preparation is still a larger challenge. The present article will highlight transmission, pandemic status, genetic diversity current antiviral therapy, and vaccine trials for COVID-19.

引用

页码：13 / 20

页数：8

共 50 条

[1] Prospection of antiviral compounds from forest plants under ongoing SARS-COV-2 pandemic
Senthilkumar, Natchiappan
Sumathi, Ramasamy
Babu, Devaraj Suresh
[J]. ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2021, 10 (01): : S195 - S208
[2] The ongoing evolution of UShER during the SARS-CoV-2 pandemic
Angie Hinrichs
Cheng Ye
Yatish Turakhia
Russell Corbett-Detig
[J]. Nature Genetics, 2024, 56 : 4 - 7
[3] The ongoing evolution of UShER during the SARS-CoV-2 pandemic
Hinrichs, Angie
Ye, Cheng
Turakhia, Yatish
Corbett-Detig, Russell
[J]. NATURE GENETICS, 2024, 56 (01) : 4 - 7
[4] Immunophenotyping of SARS-CoV-2 and vaccine design
Cimolai, Nevio
[J]. VACCINE, 2022, 40 (30) : 3985 - 3986
[5] Immunophenotyping of SARS-CoV-2 and vaccine design
Cimolai, Nevio
[J]. VACCINE, 2022, 40 (29) : 3985 - 3986
[6] The Novel Coronavirus (SARS-CoV-2) Pandemic
Hsu, Li Yang
Chia, Po Ying
Lim, Jeremy F. Y.
[J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2020, 49 (03) : 105 - 107
[7] Pediatric endoscopic surgery during the ongoing SARS-CoV-2 pandemic
Amulya K. Saxena
[J]. Journal of Pediatric Endoscopic Surgery, 2021, 3 (2) : 63 - 64
[8] Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça
Reka Lorincz
Paul Boucher
David T. Curiel
[J]. npj Vaccines, 6
[9] SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
Xiantao Zhang
Hui Zhang
Xin He
[J]. Signal Transduction and Targeted Therapy, 7
[10] Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Mendonca, Samir Andrade
Lorincz, Reka
Boucher, Paul
Curiel, David T.
[J]. NPJ VACCINES, 2021, 6 (01)

← 1 2 3 4 5 →